Jill P Buyon Selected Research

Neonatal Systemic lupus erythematosus

6/2022	Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
1/2020	A review of fetal and neonatal consequences of maternal systemic lupus erythematosus.
12/2018	Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.
9/2017	Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.
9/2017	Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.
5/2017	Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.
1/2016	Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.
1/2016	Endosomal Toll-like receptors in clinically overt and silent autoimmunity.
8/2015	Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.
11/2014	Prevention and treatment in utero of autoimmune-associated congenital heart block.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jill P Buyon Research Topics

Disease

47	Congenital heart block 10/2020 - 01/2002
40	Neonatal Systemic lupus erythematosus 06/2022 - 01/2002
40	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2002
18	Inflammation (Inflammations) 01/2019 - 06/2002
14	Cicatrix (Scar) 11/2017 - 01/2003
13	Fibrosis (Cirrhosis) 09/2017 - 08/2002
11	Lupus Nephritis 01/2022 - 07/2005
7	Nephritis 01/2021 - 07/2005
7	Heart Block 02/2016 - 08/2005
6	Exanthema (Rash) 01/2022 - 09/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2003
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 10/2010
5	Heart Diseases (Heart Disease) 01/2020 - 10/2009
4	COVID-19 08/2021 - 01/2020
3	Rheumatic Diseases (Rheumatism) 07/2021 - 09/2002
3	Thrombosis (Thrombus) 07/2021 - 06/2005
3	Cardiomyopathies (Cardiomyopathy) 11/2014 - 08/2010
2	Atrioventricular Block 06/2022 - 07/2012
2	Cardiotoxicity 10/2020 - 09/2017
2	Pre-Eclampsia (Preeclampsia) 01/2019 - 01/2009
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017 - 08/2004
2	Disease Progression 01/2016 - 01/2016
2	Hypertension (High Blood Pressure) 01/2016 - 01/2009
2	Vascular System Injuries 07/2005 - 02/2005
1	Reinfection 08/2021
1	Toxic Optic Neuropathy 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Atherosclerosis 01/2019
1	Albuminuria 01/2018
1	Myocardial Infarction 01/2018
1	Ischemic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

41	AntibodiesIBA 06/2022 - 01/2002
38	AutoantibodiesIBA 01/2021 - 01/2002
14	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
12	SS-A antibodiesIBA 01/2022 - 12/2007
10	AntigensIBA 01/2021 - 01/2003
9	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2010
8	Immunoglobulin G (IgG)IBA 08/2021 - 01/2002
7	RibonucleoproteinsIBA 09/2017 - 10/2003
7	Dexamethasone (Maxidex)FDA LinkGeneric 09/2012 - 06/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2004
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 10/2010
5	Proteins (Proteins, Gene)FDA Link 06/2017 - 12/2007
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2007 - 09/2003
4	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2010
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2016 - 06/2005
4	Urokinase Plasminogen Activator ReceptorsIBA 08/2015 - 08/2010
4	CytokinesIBA 08/2004 - 02/2003
3	EnzymesIBA 06/2022 - 03/2012
3	ImmunosorbentsIBA 06/2022 - 03/2012
3	Antinuclear AntibodiesIBA 01/2022 - 08/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
3	Antiphospholipid AntibodiesIBA 01/2018 - 01/2016
3	Complement System Proteins (Complement)IBA 01/2018 - 11/2006
3	LigandsIBA 11/2017 - 02/2010
3	CreatinineIBA 06/2017 - 01/2009
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2015 - 11/2011
3	Plasminogen Activators (Plasminogen Activator)IBA 08/2015 - 11/2011
3	AutoantigensIBA 05/2015 - 01/2002
3	Biological ProductsIBA 10/2014 - 08/2004
3	Endothelial Protein C ReceptorIBA 03/2012 - 07/2005
3	Peptides (Polypeptides)IBA 03/2009 - 08/2005
2	Interferon Type IIBA 01/2022 - 02/2008
2	Antimalarials (Antimalarial Agents)IBA 10/2020 - 02/2016
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 02/2010
2	Estrogens (Estrogen)FDA Link 01/2020 - 06/2005
2	Fluorinated SteroidsIBA 09/2017 - 01/2016
2	Toll-Like Receptor 7IBA 02/2016 - 03/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 05/2005
2	EpitopesIBA 05/2015 - 06/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2014 - 04/2010
2	anti-dsDNA autoantibodyIBA 12/2012 - 11/2006
2	Prednisone (Sone)FDA LinkGeneric 04/2010 - 11/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2010 - 12/2005
2	Oral ContraceptivesIBA 12/2005 - 04/2002
2	Anticardiolipin AntibodiesIBA 12/2005 - 06/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2005 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004 - 09/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2021
1	Immunoglobulin A (IgA)IBA 07/2021
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	baricitinibIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2019
1	Sialic Acid Binding Ig-like Lectin 1IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Malondialdehyde (Propanedial)IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Cystatin CIBA 01/2018

Therapy/Procedure

12	Therapeutics 10/2020 - 09/2004
2	Ligation 02/2016 - 02/2010
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2005 - 04/2002
1	Secondary Prevention 01/2020
1	Immunomodulation 01/2020